![Juan Antonio Ballesteros Nobell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Juan Antonio Ballesteros Nobell
Gründer bei Vivia Biotech SL
Ursprung des Netzwerks ersten Grades von Juan Antonio Ballesteros Nobell
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Vivia Biotech SL
![]() Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain.
4
| Private Company | Biotechnology | 4 |
Novasite Pharmaceuticals, Inc.
![]() Novasite Pharmaceuticals, Inc. BiotechnologyHealth Technology Novasite Pharmaceuticals, Inc. develops optimizing genes and proteins. The private company is based in San Diego, CA and has subsidiaries in United States. The company was founded by Juan Antonio Ballesteros Nobell.
2
| Private Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Juan Antonio Ballesteros Nobell
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BG MEDICINE, INC. | Medical Specialties | Director/Board Member | |
Copenhagen Business School | College/University | Graduate Degree | |
Dako Denmark ApS
![]() Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Corporate Officer/Principal | |
University of Barcelona | College/University | Undergraduate Degree | |
Escuela de Alta Dirección y Administración | College/University | Graduate Degree | |
Advanced Marker Discovery SL
![]() Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain. | Medical Specialties | Director/Board Member | |
LETI Pharma SLU
![]() LETI Pharma SLU Air Freight/CouriersTransportation Laboratorios LETI SL develops and produces pharmaceutical products. It offers dermatology, immunology and vaccines, diagnostics and oncology services. The company was founded by Pedro Domingo Sanjuán in 1919 and is headquartered in Barcelona, Spain. | Air Freight/Couriers | Corporate Officer/Principal | |
Werfen SA
![]() Werfen SA Medical SpecialtiesHealth Technology Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain. | Medical Specialties | Sales & Marketing | |
EADA Business School | College/University | Graduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
Fordham University
![]() Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Graduate Degree | |
Instituto de Estudios Superiores de la Empresa | College/University | Graduate Degree | |
CUBE Labs Srl
![]() CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
Vitro SA
![]() Vitro SA Financial ConglomeratesFinance Vitro SA provides investment services. The private company is located in Mexico. Ferran Prat has been the CEO of the Mexican company since 2023. | Financial Conglomerates | Chief Executive Officer | |
Zipprime Ltd. | Consultant / Advisor | ||
Ventac Partners AB | Corporate Officer/Principal | ||
Universida de Alcalá de Henares | College/University | Undergraduate Degree | |
Escuela Superior de Administración y Dirección de Empresas | College/University | Graduate Degree | |
Cellerix SA
![]() Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Universidad Complutense de Madrid | College/University | Doctorate Degree | |
SGX Pharmaceuticals, Inc.
![]() SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
OPGEN, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Medical/Nursing Services | Director/Board Member | |
Glaxo Group Research Ltd. | Corporate Officer/Principal | ||
Gyrasol Technologies | Director/Board Member | ||
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SV Health Investors LLC
![]() SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Corporate Officer/Principal | |
Asociacion De Empresas Biotecnologicas
![]() Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Biotechnology | Director/Board Member | |
SAIC-Frederick, Inc.
![]() SAIC-Frederick, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
University of Birmingham | College/University | Doctorate Degree | |
BIOVERATIV INC | Biotechnology | Corporate Officer/Principal | |
Biogen-Idec Pharmaceuticals, Inc.
![]() Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duran Audio BV
![]() Duran Audio BV Electronic Production EquipmentElectronic Technology Part of Samsung Electronics Co., Ltd., Duran Audio BV is a Dutch company that manufactures and distributes audio equipment. The company is based in Zaltbommel, the Netherlands. Duran Audio was acquired by Harman International Industries, Inc., part of Samsung Electronics Co., Ltd. from March 13, 2017 on October 17, 2013 for $40.47 million. | Electronic Production Equipment | Chief Tech/Sci/R&D Officer | |
Pheno Therapeutics Ltd.
![]() Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
New York State Bar Association
![]() New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Instituto de Empresa SL | College/University | Masters Business Admin | |
Chemo Ibérica SA
![]() Chemo Ibérica SA Pharmaceuticals: MajorHealth Technology Chemo Ibérica SA develops and distributes pharmaceutical products. It also produces veterinery finished products, raw materials, intermediate products from synthesis and other fine chemicals. Its activities are grouped under chemistry, generics, healthcare, veterinery and agrochemicals. The company also operates in India, China, Italy, Guatemala, Switzerland, Hungary, Argentina, Belgium & Luxembourg through subsidiaries, joint ventures and commercial offices. Chemo Iberica was founded in 1977 and is headquartered in Madrid, Spain. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 17 |
Spanien | 15 |
Vereinigtes Königreich | 6 |
Dänemark | 3 |
Italien | 2 |
Sektoral
Health Technology | 15 |
Consumer Services | 13 |
Commercial Services | 7 |
Finance | 4 |
Transportation | 2 |
Operativ
Corporate Officer/Principal | 15 |
Director/Board Member | 10 |
Graduate Degree | 8 |
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Juan Antonio Ballesteros Nobell
- Unternehmensverbindungen